Figure 3 | Blood Cancer Journal

Figure 3

From: Establishment of a standardized multiplex assay with the analytical performance required for quantitative measurement of BCR–ABL1 on the international reporting scale

Figure 3

Comparison with existing LDTs. (a) Description of sample set and summary of results. (b) Quantitative analysis on 103 archived total RNA samples with LDT results ranging from >100 to about 0.001% ratio. Percent ratio and calculated paired Pearson correlation values are shown for each independent method. (c) Representative examples of CE traces for BCR–ABL1 amplicons analyzed in the FAM channel of a 3130xl CE instrument. Nucleotide (nt) size for the expected b2a2, e1a2 and b3a2 fragments are shown.

Back to article page